Matches in Wikidata for { <http://www.wikidata.org/entity/Q66062006> ?p ?o ?g. }
Showing items 1 to 33 of
33
with 100 items per page.
- Q66062006 description "clinical trial" @default.
- Q66062006 description "ensayu clínicu" @default.
- Q66062006 description "klinisch onderzoek" @default.
- Q66062006 description "клінічне випробування" @default.
- Q66062006 name "A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Efficacy of TAK-169 in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)" @default.
- Q66062006 name "A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Efficacy of TAK-169 in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)" @default.
- Q66062006 type Item @default.
- Q66062006 label "A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Efficacy of TAK-169 in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)" @default.
- Q66062006 label "A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Efficacy of TAK-169 in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)" @default.
- Q66062006 prefLabel "A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Efficacy of TAK-169 in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)" @default.
- Q66062006 prefLabel "A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Efficacy of TAK-169 in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)" @default.
- Q66062006 P1050 Q66062006-114EF555-881B-4BAC-8CEE-F4AC93CB517D @default.
- Q66062006 P1132 Q66062006-1558F023-254F-48A9-A9D7-02B59E877CE2 @default.
- Q66062006 P1476 Q66062006-005BCD05-2EAE-428E-A960-7F474DFD91CD @default.
- Q66062006 P2899 Q66062006-100EF874-BE21-41CE-98F3-223709B255FA @default.
- Q66062006 P3098 Q66062006-8A1BEE82-5A5D-4BF6-8B02-F69E1210853D @default.
- Q66062006 P31 Q66062006-5EF3D5F2-2F60-400D-8F8F-AF9A4996877E @default.
- Q66062006 P4844 Q66062006-9502623E-9508-4D14-AB49-2335A725525F @default.
- Q66062006 P580 Q66062006-3B8C2BEC-40A1-4BE6-BBFC-BBE34BB65D6B @default.
- Q66062006 P582 Q66062006-CBF7C4CF-4401-473C-86F0-FF27849EEB7C @default.
- Q66062006 P6099 Q66062006-6CCE98FB-CE83-4A9A-9CC2-52A069BE5F3A @default.
- Q66062006 P8363 Q66062006-72DB45B2-7A5C-4C93-B8E7-ECA7E12F77CA @default.
- Q66062006 P1050 Q467635 @default.
- Q66062006 P1132 "+102" @default.
- Q66062006 P1476 "A Phase 1, Open-Label, Dose-Escalation, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TAK-169 in Patients With Relapsed or Refractory Multiple Myeloma" @default.
- Q66062006 P2899 "+18" @default.
- Q66062006 P3098 "NCT04017130" @default.
- Q66062006 P31 Q30612 @default.
- Q66062006 P4844 Q5222113 @default.
- Q66062006 P580 "2019-09-01T00:00:00Z" @default.
- Q66062006 P582 "2023-01-17T00:00:00Z" @default.
- Q66062006 P6099 Q5452194 @default.
- Q66062006 P8363 Q78089383 @default.